Favourable Efficacy and Tolerability With Long-term Solifenacin Treatment Support High Patient Persistence

Haab F1, Halaska M2, Klaver M3, for the Solifenacin Study Group 1 1. Department of Urology, Hopital Tenon, Paris, France, 2. Department of Obstetrics and Gynecology, Charles University Prague, Czech Republic, 3. Yamanouchi Europe B.V., Leiderdorp, The Netherlands

Abstract